Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cebelia is a French dermo-cosmetic brand developed by Laboratoires d'Anjou, specializing in advanced skincare solutions for aesthetic medicine and dermatology. The company is recognized for its use of patented biotechnological active ingredients, such as Cebeline, a peptide fragment of Laminin 5 that accelerates skin repair by strengthening the dermal-epidermal junction. Their product range is specifically formulated to accompany medical-aesthetic procedures—including lasers, peelings, and injections—to soothe skin, reduce bruising, and optimize healing outcomes. Cebelia maintains strong ties with French public research institutions like CNRS and INSERM to validate the efficacy of its regenerative and anti-hyperpigmentation treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEBELIA.